| Inhibition of human recombinant aurora B/INCENP complex after 120 mins by IMAP fluoroscence polarization assay - BioAssay Summary Novel Aurora inhibitors were identified truncating clinical candidate GSK1070916. Many of these truncated compounds retained potent activity against Aurora B with good antiproliferative activity. Mechanistic studies suggested that these compounds, depending on the substitution pattern, may or may not exert their antiproliferative effects via inhibition of Aurora B. The SAR results from this investigation will be presented with an emphasis on the impact structural changes have on the cellular phenotype. ..more |
_ | |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
BioActive Compounds: 9 Description: Title: Discovery of a new series of Aurora inhibitors through truncation of GSK1070916. Abstract: Novel Aurora inhibitors were identified truncating clinical candidate GSK1070916. Many of these truncated compounds retained potent activity against Aurora B with good antiproliferative activity. Mechanistic studies suggested that these compounds, depending on the substitution pattern, may or may not exert their antiproliferative effects via inhibition of Aurora B. The SAR results from this investigation will be presented with an emphasis on the impact structural changes have on the cellular phenotype. (PMID: 20335034) Comment Compounds with activity <= 50uM or explicitly reported as active by ChEMBL are flagged as active in this PubChem assay presentation. Putative Target: ChEMBL Target ID: 22226 Target Type: UNCHECKED Pref Name: Unchecked Confidence: Direct protein complex subunits assigned Relationship Type: Direct protein target assigned Categorized Comment ChEMBL Assay Type: Binding ChEMBL Assay Data Source: Scientific Literature ChEMBL Target ID: 22226 ChEMBL target type: NULL Result Definitions
* Activity Concentration. Data Table (Concise)
PageFrom: |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||